Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-026926
Filing Date
2021-02-23
Accepted
2021-02-23 18:46:01
Documents
2
Period of Report
2021-02-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm217706-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm217706-1_4seq1.xml 4 6847
2 EXHIBIT 24 tm217706d1_ex24.htm EX-24 7848
  Complete submission text file 0001104659-21-026926.txt   16174
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Barlow Carrolee (Reporting) CIK: 0001745316 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 21667506